Drug
Edoxaban 60 MG
Edoxaban 60 MG is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
17%
Ph not_applicable
1
17%
Ph phase_4
3
50%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(5)
Detailed Status
Completed5
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)
Trials by Status
completed583%
not_yet_recruiting117%
Recent Activity
0 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
NCT07116239
completed
Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
NCT04477837
completedphase_4
Lixiana Acute Stroke Evaluation Registry
NCT03494530
completedphase_1
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
NCT03083704
completedphase_4
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
NCT03666650
Clinical Trials (6)
Showing 6 of 6 trials
NCT07116239Not Applicable
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
NCT04477837
Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
NCT03494530Phase 4
Lixiana Acute Stroke Evaluation Registry
NCT03083704Phase 1
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
NCT03666650Phase 4
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
NCT02567461Phase 4
Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6